Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,955 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06919003RecruitingPhase 2
Improving kidney transplant with a single injection of a protective protein
This trial tests whether a single injection of C1 esterase inhibitor into a donated kidney during preservation can improve transplant outcomes. It is for adults on dialysis waiting for a deceased-donor kidney who meet specific blood and tissue matching requirements.
Los Angeles, CaliforniaAges 18–75 - NCT06919328Recruiting
Testing a new form of Niagen for energy and fatigue
This trial tests how well a new injectable form of Niagen (a supplement that may boost cellular energy) is absorbed and tolerated compared to NAD+. It may help if you are between 40 and 65, live near the study site, and feel unusually tired.
Huntsville, AlabamaAges 40–65 - NCT06922994RecruitingPhase 2
Testing atorvastatin for arrhythmogenic cardiomyopathy
This trial tests if a common cholesterol medicine, atorvastatin, can slow the progression of arrhythmogenic cardiomyopathy, a genetic heart condition that can cause abnormal heart rhythms. If you have this condition, joining this study may help researchers find a new way to protect your heart.
Pavia, PVAges 18 years+ - NCT06923709RecruitingPhase 2
Amiloride for slowing kidney disease progression
This trial tests if the drug amiloride can help slow down chronic kidney disease. It may be an option if you have moderate kidney function and high protein in your urine.
OdenseAges 18 years+ - NCT06923787RecruitingPhase 2
Lidocaine for colon cancer surgery recovery
This trial tests whether giving lidocaine through an IV during and after colon cancer surgery can help with recovery and boost your immune system. It's for people having laparoscopic colon surgery who haven't had chemotherapy before.
LjubljanaAges 18–80 - NCT06924658RecruitingPhase 2
Metformin for gout patients study
This trial tests if metformin, a common diabetes drug, can help people with gout. It aims to see if the drug is safe and effective for reducing gout symptoms.
TantaAges 18–60 - NCT06925061RecruitingPhase 2
Testing EXL01 to prevent Crohn's disease return after surgery
This study tests a new oral treatment called EXL01 to see if it can prevent Crohn's disease from coming back after surgery to remove part of the small and large intestine. It may be an option if you are not planning to use strong immune-suppressing drugs (except anti-TNF) in the next 6 months.
Clermont-FerrandAges 18 years+ - NCT06927076Recruiting
DMT with propofol for depression
This study tests whether a combination of DMT (a psychedelic) and propofol (a sedative) can help treat depression. You will receive both medicines in a hospital setting, and the team will monitor your response.
BaselAges 21 years+ - NCT06928389RecruitingPhase 3
Ivonescimab plus docetaxel for advanced lung cancer
This trial tests a new drug called ivonescimab combined with a chemotherapy drug (docetaxel) for advanced non-small cell lung cancer. It's for people who have already tried platinum-based chemo and a PD-1/PD-L1 inhibitor, and who have not had docetaxel before.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06930885RecruitingPhase 3
Polypill and colchicine for heart and artery risk
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Maceió, AlabamaAges 45 years+ - NCT06931028RecruitingPhase 3
Study of IBI362 for sleep apnea with obesity
This study tests an investigational medication (IBI362) to see if it can improve sleep apnea in people with obesity. You might qualify if you have moderate to severe sleep apnea and a BMI of 28 or higher, whether or not you currently use a CPAP machine.
BeijingAges 18 years+ - NCT06933706RecruitingPhase 2
Losartan for better recovery after multi-ligament knee injury
This trial tests if losartan, a blood pressure medication, can improve healing and recovery after surgery for a multi-ligament knee injury. Taking losartan for 30 days after surgery may reduce stiffness and help you get back to your normal activities sooner.
Lexington, KentuckyAges 18–40 - NCT06934408RecruitingPhase 1
Safety study of HRS-5817 injection in healthy adults
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
Hefei, AnhuiAges 18–55 - NCT06935045Recruiting
Drinking alcohol in hot weather study
This trial looks at how drinking alcohol affects your body when it's hot outside. It may help us understand the risks of drinking in the heat.
Thunder Bay, OntarioAges 19 years+ - NCT06935682RecruitingPhase 1
Safety study of Y-4 tablets in healthy volunteers
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
Beijing, Beijing MunicipalityAges 18–45 - NCT06937190Recruiting
Does creatine before sleep improve power in active women?
This study tests if taking a small dose of creatine before bed helps women who exercise regularly perform better on power-based activities like jumping and sprinting. It's designed for healthy, young women who already do resistance training and want to see if a simple supplement can boost their nighttime recovery and next-day performance.
Shabestar, East Azerbaijan ProvinceAges 18–25 - NCT06937294RecruitingPhase 4
Metformin for diabetes from chronic pancreatitis
This trial tests if metformin is safe and effective for people who developed diabetes after being diagnosed with chronic pancreatitis. You must not have taken any diabetes medication before.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06937853Recruiting
Genes and painkiller response for tooth pain
This trial tests whether your genes affect how well a common painkiller (NSAID) works for tooth pain after a root canal procedure. It may help find the best pain relief for you.
Erzurum, ErzurumAges 18–65 - NCT06938269RecruitingPhase 1
Study of MWN109 tablets in healthy adults
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
Adelaide, South AustraliaAges 18–60 - NCT06938464Recruiting
Probiotics to prevent gestational diabetes in high-risk women
This study tests whether taking probiotics (friendly bacteria) during early pregnancy can help prevent gestational diabetes in women who are at higher risk for it.
Hangzhou, ZhejiangAges 18–50 - NCT06938763RecruitingPhase 1
Safety study of J4 in healthy volunteers
This trial tests a new drug called J4 in healthy adults to see if it is safe and how the body processes it. Healthy volunteers aged 18 to 64 may join to help researchers learn about the drug's effects.
TaipeiAges 18–64 - NCT06938867RecruitingPhase 1/Phase 2
Study of SNIPR001 for resistant gut bacteria before stem cell transplant
This study tests an experimental oral medicine called SNIPR001. It is designed to reduce resistant E. coli bacteria in the gut before your stem cell transplant, possibly lowering the risk of infection.
Duarte, CaliforniaAges 18 years+ - NCT06939088RecruitingPhase 2
Tirzepatide for alcohol reduction in schizophrenia
This trial tests if tirzepatide, a once-weekly injection, can help reduce heavy drinking in people who have both schizophrenia and alcohol use disorder. If you struggle with alcohol and have stable schizophrenia, this study may offer a new treatment option.
Aalborg, DenmarkAges 18–70 - NCT06940011RecruitingPhase 2
Endocalyx for hard-to-treat high blood pressure
This trial tests a new treatment called Endocalyx for people whose high blood pressure doesn't get better with multiple medications. It aims to see if Endocalyx can help lower blood pressure when standard medicines aren't enough.
Amsterdam, North HollandAges 18 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,955 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.